Vimarsana
Biggest News Aggregation in the World

Page 20 - Double Blind News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Double Blind. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Double Blind Today - Breaking & Trending Today

Probiotic strain SNZ 1969 helps manage IBS-D & IBS-C symptoms effectively, latest clinical study shows - Vimarsana News

Probiotic strain SNZ 1969 helps manage IBS-D & IBS-C symptoms effectively, latest clinical study shows

Hyderabad (Telangana) [India], November 29 (ANI/PRNewswire): Latest study shows Sanzyme Biologics's Bacillus coagulans SNZ 1969 (Weizmannia coagulans SNZ 1969), a natural spore forming probiotic strain over five decades of use and more than 30 human studies across age groups found to be effective in managing IBS symptoms. This study is unique as it covers both the IBS-Diarrhea and IBS-Constipation groups with larger number of subjects. Irritable bowel syndrome (IBS) is one of the most common disorders of gut-brain interaction, estimated to affect around 11 per cent people globally. The out...

Related Topics:
Sanzyme BiologicsHyderabad Telangana India Ovember 29 Ani Prnewswire Latest Study Shows Sanzyme Biologics 39s Bacillus Coagulans Snz 1969 Weizmannia A Natural Spore Forming Probiotic Strain Over Five Decades Of Use And More Than 30 Human Studies Across Age Groups Found To Be Effective In Managing Ibs Symptoms This Study Is Unique As It Covers Both The Diarrhea Constipation With Larger Number Subjects Irritable Bowel Syndrome One Most Common Disorders Gut Brain InteractionStimated To Affect Around 11 Per Cent People Globally The Outcome Of This Study Will Be Significant Supplement Manufacturers As It Can Help Design Products Address Consumer Need For Managing Ibs Symptoms Witha Scientifically Studied Probiotic Strain Several FactorsUch As The Increasing Fear Of Antibiotic ResistanceHe Increasing Demand Of Consumers For Natural Substitutes DrugsNd The Emergence Of Scientific And Clinical Evidence Showing Efficacy ProbioticsAve Contributed To Many Health Professionals Considering Probiotics As An Alternative Drug Remedies Ina RandomizedDouble BlindPlacebo Controlled StudyRobiotic Potential Of Snz 1969 Has Been Studied In Subjects With Constipation Predominant Irritable Bowel Syndrome Ibsc And Diarrhea Ibsd Significant Reduction Gsrs Ibs Score Was Seen Both The Treatment Group Compared To Placebop Lt 0 0001 Well Tolerated Showed Alleviation Associated Clinical Symptoms Placebo Improved Quality Life Patients This Study Conducted At Apollo HospitalsNdia And Published In The International Journal Of Basic Amp Clinical Pharmacology Https Www Ijbcp Com Index Php Article View 5120 Same Strain Has Been Studied Earlier For Gastrointestinal DiscomfortNtestinal Motility And Intermittent Constipation Among Healthy Subjects Gi Discomfort Study Showed An Improvement In Total Soda ScoresNcluding Specific Symptoms Such As Burping BelchingPassing GasBad BreathNd Sour Taste Compared With Placebo Intestinal Motility Study Concluded That Snz 1969 Reaches The Colon Intact And Ameliorates Gut Microbiota Composition Sanzyme Biologics Was Incorporated In As Uni Sankyo Over Last Five Decades Established Its Strength Probiotics By Developing Scientifically Studied Well Documented Probiotic StrainsIoneered Their Applications Beyond Human Health Into AquaOultry And Bioremediation Sanzyme Biologics Has Market Presence In Over 40 Countries To Know MoreIsit Https Www Sanzymebiologics Com Or Contact Info Ph 91 40 48589999 This Story Is Provided By Prnewswire Ani Will Not Be Responsible In Any Way For The Content Of Article
Tropical Gothclub - Tropical Gothclub review - Vimarsana News

Tropical Gothclub - Tropical Gothclub review

So polished and pristine that the only pity is that it didn’t come sooner.

Source: diymag.com
Aptabio to present results of Isuzinaxib Phase 2 study at The American Society of Nephrology (ASN)'s Kidney Week 2022 - Vimarsana News

Aptabio to present results of Isuzinaxib Phase 2 study at The American Society of Nephrology (ASN)'s Kidney Week 2022

Aptabio's Isuzinaxib (APX-115) proves its effect on a key kidney function marker in a Phase 2 clinical study in patients with diabetes and chronic kidney...

FBI preview: A special Sunday episode could lead to an agent's exit - Vimarsana News

FBI preview: A special Sunday episode could lead to an agent's exit

A special Sunday episode of FBI has the team tracking a missing child while the Scola-Nina relationship faces a huge challenge.

Nektar Therapeutics Reports Third Quarter 2022 Financial Results - Vimarsana News

Nektar Therapeutics Reports Third Quarter 2022 Financial Results

/PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the third quarter ended September 30, 2022. Cash and investments in...